MarketPulse

PROCEPT BioRobotics

4 articles
BenzingaBenzinga··Glancy Prongay Wolke & Rotter Llp

PRCT Stock Plunges 15% After Weak Earnings, Securities Fraud Probe Widens

PROCEPT BioRobotics stock plunges 15% following disappointing earnings and cut guidance; securities fraud investigation underway seeking affected shareholders.
PRCTstock price declineshareholder litigation
BenzingaBenzinga··Law Offices Of Frank R. Cruz

PROCEPT BioRobotics Faces Securities Fraud Probe After Brutal Revenue Guidance Cut

PROCEPT BioRobotics faces securities fraud probe after slashing 2026 revenue guidance by up to $40M, citing eliminated bulk discounts. Stock fell 15.12%.
PRCTinvestor lossesstock price decline
BenzingaBenzinga··Glancy Prongay Wolke & Rotter Llp

PRCT Stock Plunges 15% After Revenue Miss Triggers Securities Fraud Investigation

PROCEPT BioRobotics faces securities fraud investigation after missing earnings and cutting 2026 guidance by $20-30 million, triggering a 15% stock plunge.
PRCTshareholder lawsuitstock price decline
BenzingaBenzinga··Business Wire

PROCEPT BioRobotics Faces Securities Fraud Investigation After Earnings Miss, Stock Plunges 15%

Law firm launches investigation into $PRCT over alleged securities violations following disappointing earnings report and major revenue guidance cut.
PRCTstock declineshareholder lawsuit